Penumbra Q4 2021 Earnings Report
Key Takeaways
Penumbra, Inc. reported a revenue of $204.0 million for the fourth quarter of 2021, representing a 22.2% increase compared to the fourth quarter of 2020. The company's gross profit for the quarter was $125.4 million, or 61.5% of total revenue.
Total revenue increased to $204.0 million for the fourth quarter of 2021, up 22.2% compared to Q4 2020.
US revenue for Q4 2021 was $144.5 million, a 23.7% increase year-over-year.
Revenue from vascular products grew to $113.6 million, a 30.4% increase, while neuro products grew to $90.4 million, a 13.3% increase.
Gross profit for Q4 2021 was $125.4 million, or 61.5% of total revenue, impacted by higher labor and logistics costs.
Penumbra
Penumbra
Penumbra Revenue by Segment
Penumbra Revenue by Geographic Location
Forward Guidance
Penumbra projects total revenue for 2022 to be in the range of $860 million to $875 million, which represents growth of 15% to 17% over 2021 revenue of $747.6 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income